Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

Share Price is delayed by 15 minutes
Get Live Data
146.50    -9.50 (-6.09%)
Bid:
145.00
Ask:
148.00
Spread: 3.00 (2.069%)
Market Cap: £171.87m
SUP Live PriceLast checked at - London Stock Exchange

Intraday Supreme Plc Share Chart

AGM Trading Statement

19 Sep 2024 07:00

RNS Number : 7730E
Supreme PLC
19 September 2024
 

19 September 2024

 

Supreme plc

("Supreme" or the "Company" or the "Group")

 

AGM Trading Statement

 

Positive momentum continued in H1 2025

 

Supreme (AIM: SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer goods, announces that Chairman Paul McDonald will provide the following statement at its Annual General Meeting at 9.00 a.m. today:

 

"Supreme traded strongly across the year ended 31 March 2024, delivering record organic revenue and profit growth, and ending the year debt-free. We again saw strong consumer demand for our products, which continue to offer both high quality and value at a time when household discretionary spend remains under pressure.

 

Pleasingly, we have continued to build on this positive trading momentum in the first half of the current financial year ("H1 2025").

 

The earnings enhancing acquisition of soft drinks business Clearly Drinks (completed in June 2024) has accelerated our broader diversification strategy, with our teams already leveraging Supreme's extensive UK distribution network to create additional cross-selling opportunities and expand our market footprint.

 

Post the acquisition of Clearly Drinks, non-vape annualised sales are now expected to exceed £100 million. Acquisitions continue to underpin Supreme's growth ambitions, and the current M&A pipeline is strong with opportunities spanning multiple product verticals and markets.

 

The core lines within our Vaping category continue to perform well and we remain well positioned to comfortably manage the anticipated changes to the UK vaping market, having continued investment in rechargeable pod system vaping devices, adapted our flavour range and own-brand packaging, and ensured all retail partners enforce rigid age verification checks.

 

As an industry leader, Supreme acknowledges the wider concerns of underage vaping and remains fully supportive of proposed legislative changes in the UK. Details of the proactive measures that Supreme is taking to curb underage vaping are available to read in our latest Annual Report on our website.

 

Following a solid start in H1 2025, Supreme expects trading for the year ended 31 March 2025 ("FY 2025") to be in line with market expectations1."

 

 

1 Company compiled analyst consensus for the year ending 31 March 2025 prior to release of this announcement was Adjusted EBITDA2 of £37 million

2 Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Shore Capital (Nominated Adviser and Joint Broker)

Mark Percy / David Coaten / Rachel Goldstein - Corporate Advisory

Ben Canning - Corporate Broking

 

+44 (0)20 7408 4090

Zeus (Joint Broker)

Jordan Warburton / Alex Campbell-Harris - Investment Banking

Benjamin Robertson - Corporate Broking

 

+44 (0)161 831 1512

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill / Anna Stacey

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

About Supreme

 

Supreme supplies products across six categories; Batteries, Lighting, Vaping, Sports Nutrition and Wellness, Branded Distribution and Soft Drinks. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,000 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland, Waitrose, Aldi and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape, has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites, and has recently expanded into the soft drinks market with the acquisition of Clearly Drinks, adding established brands such as Perfectly Clear and Northumbria Spring to its portfolio.

 

https://investors.supreme.co.uk/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMQKFBQOBKDNCD
Date   Source Headline
25th Jul 20227:00 amRNSDirector Share Purchase
18th Jul 20224:41 pmRNSDirector Share Purchase
12th Jul 20229:30 amRNSHolding(s) in Company
12th Jul 20229:19 amRNSDirector Share Purchase
8th Jul 20225:14 pmRNSHolding(s) in Company
6th Jul 202212:34 pmRNSHolding(s) in Company
5th Jul 202211:05 amRNSSecond Price Monitoring Extn
5th Jul 202211:00 amRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSFinal Results
21st Jun 20227:00 amRNSNotice of Results & Investor Presentation
13th Jun 20227:00 amRNSAcquisition of Liberty Flights Holdings Limited
10th May 20227:00 amRNSSale of McColl's Retail Group
28th Apr 202212:35 pmRNSHolding(s) in Company
14th Apr 202212:00 pmRNSInvestor Presentation
12th Apr 20229:05 amRNSSecond Price Monitoring Extn
12th Apr 20229:00 amRNSPrice Monitoring Extension
12th Apr 20227:00 amRNSYear End Trading Update
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:01 pmRNSPrice Monitoring Extension
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:00 amRNSPrice Monitoring Extension
7th Dec 20217:00 amRNSHalf-year Results
30th Nov 202111:30 amRNSInvestor Presentation
18th Oct 20217:07 amRNSTrading Update & Notice of Results
30th Sep 20213:05 pmRNSResults of AGM
31st Aug 20217:00 amRNSAvailability of Annual Report & Notice of AGM
20th Jul 20217:00 amRNSUnaudited Preliminary Results
19th Jul 20217:00 amRNSLaunch of Sealions Vitamin brand
8th Jul 20217:00 amRNSNotice of Results & Investor Presentation
1st Jul 20217:00 amRNSAcquisition of brands of SCI-MX Limited
11th Jun 20217:00 amRNSAcquisition of Vendek Limited
9th Jun 20217:00 amRNSExercise of options and total voting rights
4th May 20217:00 amRNSTrading Update
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
19th Mar 20211:13 pmRNSGrant of Options under 2021 SAYE Scheme
15th Mar 20217:00 amRNSCompletion of McColl’s roll-out
10th Mar 20217:00 amRNSDirector/PDMR Shareholding
1st Mar 20219:00 amRNSPrice Monitoring Extension
2nd Feb 20214:37 pmRNSHolding(s) in Company
1st Feb 20217:00 amRNSAIM Admission & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.